Abstract

Lung infection named as COVID-19 is an infectious disease caused by the most recently discovered coronavirus 2 (SARS-CoV-2). CT (computed tomography) has been shown to have good sensitivity in comparison with RT-PCR, particularly in early stages. However, CT findings appear to not always be related to a certain clinical severity. The aim of this study is to evaluate a correlation between the percentage of lung parenchyma volume involved with COVID-19 infection (compared to the total lung volume) at baseline diagnosis and correlated to the patient’s clinical course (need for ventilator assistance and or death). All patients with suspected COVID-19 lung disease referred to our imaging department for Chest CT from 24 February to 6 April 2020were included in the study. Specific CT features were assessed including the amount of high attenuation areas (HAA) related to lung infection. HAA, defined as the percentage of lung parenchyma above a predefined threshold of −650 (HAA%, HAA/total lung volume), was automatically calculated using a dedicated segmentation software. Lung volumes and CT findings were correlated with patient’s clinical course. Logistic regressions were performed to assess the predictive value of clinical, inflammatory and CT parameters for the defined outcome. In the overall population we found an average infected lung volume of 31.4 ± 26.3% while in the subgroup of patients who needed ventilator assistance and who died as well as the patients who died without receiving ventilator assistance the volume of infected lung was significantly higher 41.4 ± 28.5 and 72.7 ± 36.2 (p < 0.001). In logistic regression analysis best predictors for ventilation and death were the presence of air bronchogram (p = 0.006), crazy paving (p = 0.007), peripheral distribution (p < 0.001), age (p = 0.002), fever at admission (p = 0.007), dyspnea (p = 0.002) and cardiovascular comorbidities (p < 0.001). In multivariable analysis, quantitative CT parameters and features added incremental predictive value beyond a model with only clinical parameters (area under the curve, 0.78 vs. 0.74, p = 0.02). Our study demonstrates that quantitative evaluation of lung volume involved by COVID-19 pneumonia helps to predict patient’s clinical course.

Highlights

  • Lung infection named as COVID-19 pneumonia is an infectious disease caused by the most recently discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus

  • COVID-19 pneumonia has various non-specific imaging features that can be found in other lung infections, such as Influenza A (H1N1), Cytomegalovirus (CMV), other coronavirus (SARS, MERS), streptococcus and atypical pneumonias

  • The aim of this study is to evaluate a correlation between the volume of lung parenchyma involved with COVID-19 infection and the clinical outcome in a population of patients with cardiovascular disease

Read more

Summary

Introduction

Lung infection named as COVID-19 pneumonia is an infectious disease caused by the most recently discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus. Imaging and the RT-PCR test, are considered as the reference standard for final diagnosis [1] In this scenario it has been shown that chest X-ray is burdened by low sensitivity in identifying the lung changes of COVID-19 in the early stages of the disease [2]. The aim of this study is to evaluate a correlation between the volume of lung parenchyma involved with COVID-19 infection (expressed as a percentage in comparison with the total lung volume) and the clinical outcome in a population of patients with cardiovascular disease. We aim to identify a specific lung involvement threshold that could predict the need for non-invasive or invasive ventilatory assistance or the onset of respiratory failure to improve the downstream management of these patients. We analyzed subgroups with different comorbidities and blood tests to find further independent predictors for ventilatory assistance

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call